Anthony Harrison - Concepedia

Author

Anthony Harrison

Pfizer (United Kingdom)

Also Known As

Anthony C. Harrison, Anthony Harrison

Publications

889

Citations

H-Index

Concepts

All Affiliations

Pfizer (United Kingdom)Pfizer (United States)Roche (Switzerland)University of Manchester

About

Anthony Harrison is an author at Pfizer (United Kingdom) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	290
2	Natural Sciences	2	2	30
3	Social Sciences	1	1	63
4	Allergy	1	1	19
5	Biochemistry	1	1	13

Anthony Harrison

Publications

782

Citations

H-Index

Page 1

	Year	Citations
Prediction of Human Intestinal First-Pass Metabolism of 25 CYP3A Substrates from In Vitro Clearance and Permeability Data Michael Gertz, Anthony Harrison, J. Brian Houston, Drug Metabolism and Disposition	2010	295
The mechanism of bioactivation and antigen formation of amodiaquine in the rat Anthony Harrison, Neil R. Kitteringham, Janet Clarke, Biochemical Pharmacology MedicineImmunologyAntigen FormationPharmacologyOxidative Stress	1992	104
Pharmacology of Basimglurant (RO4917523, RG7090), a Unique Metabotropic Glutamate Receptor 5 Negative Allosteric Modulator in Clinical Development for Depression Lothar Lindemann, Richard H. Porter, Sebastian H. Scharf, Journal of Pharmacology and Experimental Therapeutics	2015	102
Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators: Discovery of 2-Chloro-4-[1-(4-fluorophenyl)-2,5-dimethyl-1<i>H</i>-imidazol-4-ylethynyl]pyridine (Basimglurant, RO4917523), a Promising Novel Medicine for Psychiatric Diseases Georg Jaeschke, Sabine Kolczewski, Will Spooren, Journal of Medicinal Chemistry Psychotropic MedicationPsychopharmacologyPharmacotherapyPsychiatric DiseasesPharmaceutical Chemistry	2015	63
Antibody responses to meningococcal polysaccharide vaccine in adults without a spleen Frederick L. Ruben, William A. Hankins, Zella R. Zeigler, The American Journal of Medicine VaccinationMucosal VaccinationMeningococcal Polysaccharide VaccineVaccine DevelopmentImmunology	1984	54
Inhalation by Design: Novel Tertiary Amine Muscarinic M<sub>3</sub>Receptor Antagonists with Slow Off-Rate Binding Kinetics for Inhaled Once-Daily Treatment of Chronic Obstructive Pulmonary Disease Paul A. Glossop, Christine Watson, David Price, Journal of Medicinal Chemistry	2011	33
Comparative Analysis of CYP3A Heteroactivation by Steroid Hormones and Flavonoids in Different in Vitro Systems and Potential in Vivo Implications Jamie Henshall, Aleksandra Galetin, Anthony Harrison, Drug Metabolism and Disposition	2008	29
Discovery of PF-184563, a potent and selective V1a antagonist for the treatment of dysmenorrhoea. The influence of compound flexibility on microsomal stability Patrick S. Johnson, Thomas Ryckmans, Justin S. Bryans, Bioorganic & Medicinal Chemistry Letters Compound FlexibilityMicrosomal StabilityMedicineGynecologyPharmacotherapy	2011	20
NONLINEAR ORAL PHARMACOKINETICS OF THE α-ANTAGONIST 4-AMINO-5-(4-FLUOROPHENYL)-6,7-DIMETHOXY-2-[4-(MORPHOLINOCARBONYL)-PERHYDRO-1,4-DIAZEPIN-1-YL]QUINOLINE IN HUMANS: USE OF PRECLINICAL DATA TO RATIONALIZE CLINICAL OBSERVATIONS Anthony Harrison, Alison Betts, Katherine S. Fenner, Drug Metabolism and Disposition	2004	20
A new methodology for predicting human pharmacokinetics for inhaled drugs from oratracheal pharmacokinetic data in rats Rhys Jones, Anthony Harrison Xenobiotica AsthmaPharmacotherapyDry Powder FormulationPhysiologically-based Pharmacokinetic ModelingPharmacodynamic Modeling	2011	19

Page 1